Metformin Is Associated With Reduced Odds for Colorectal Cancer Among Persons With Diabetes

INTRODUCTION: Metformin may be associated with reduced colorectal cancer (CRC) risk, but findings from previous studies have been inconsistent and had insufficient sample sizes to examine whether the association differs by anatomic site. This study examined whether metformin was associated with redu...

Descripción completa

Detalles Bibliográficos
Autores principales: Demb, Joshua, Yaseyyedi, Armaan, Liu, Lin, Bustamante, Ranier, Earles, Ashley, Ghosh, Pradipta, Gutkind, J. Silvio, Gawron, Andrew J., Kaltenbach, Tonya R., Martinez, Maria Elena, Gupta, Samir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6890275/
https://www.ncbi.nlm.nih.gov/pubmed/31770138
http://dx.doi.org/10.14309/ctg.0000000000000092

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6890275/
https://www.ncbi.nlm.nih.gov/pubmed/31770138
http://dx.doi.org/10.14309/ctg.0000000000000092

Ejemplares similares